Directory of RSS feeds
Statistics

RSS feeds in the directory: 2817

Added today: 0

Added yesterday: 0

Business / Finance

RBC: Sistema and VTB announced the creation of a large farmholding

Banki.ru: monitoring of the banking press 28.12.2018 at 12:30

Banking and financial news on the website Banki.ru

The Company AFK "System" together with VTB Bank acquired a package of shares of JSC "Pharmaceutical company "Obolensky" (OBL Pharm) the company Alvansa Ltd, the main shareholders of which are Gazprombank and UFG Private Equity. The message about the deal posted on the website of Sistema JSFC.

the Consortium, which in addition to the VTB and "Systems" includes the management of the OP "Obolenskoe" has acquired a 95,14% stake in a pharmaceutical plant for 15.5 billion rubles, the Effective share of AFK Sistema in OBL Pharm said the deal amounted to 11.7%, says the company.

"Partners are investing through a joint holding company Ristango Holding Limited, which signed a shareholders' agreement providing for the rights of all investors to participate in management. Between Sistema and VTB also signed an agreement to acquire shares of VTB in Ristango Holding Limited no later than three years from the date of the transaction", — stated in the message.

in addition, the transaction at the beginning of 2019 can join the Russian direct investment Fund (RDIF), said the company. This will be possible "after further consideration and negotiation of the terms of such transaction from the RDIF led the consortium of investors".

"the Experience and financial resources of the VTB group will significantly enhance shareholder value and provide attractive returns as current shareholders and potential new investors," — are reported words of the first Deputy President — Chairman of Board VTB Yuri Soloviev.

Why "System" buys a plant

the Deal should help "the System", the asset which has a pharmaceutical plant Binnopharm to create a "leading pharmaceutical holding company in Russia" is able to enter the top 10 commercial companies in the pharmaceutical industry.

the Production capacity of the combined company, which will be completed in the first half of 2019 — four pharmaceutical plants in Moscow and the Moscow region.

the company will be able to produce about 200 drugs with the "flagships" in the form of venotonic "Benarus", probiotic "Maxilac" and hepaprotective "Endoxa".

that AFK "System" and the Russian-Chinese investment Fund (RCIF established by the RDIF and China investment Corporation in 2012) plan to invest in the Pharma business, RBC wrote in early October.

the Plans to acquire JSC "Pharmaceutical company "Obolensky" the interlocutors RBC was then described as "negotiations are at an advanced stage". According to sources, the initiator of the negotiation and the search farmaktivy made it "the System", whose strategy is expansion of farmapine.

Natalia DEMCHENKO